Dosage should be diminished while in the aged or debilitated since these patients might be additional sensitive to barbiturates. Dosage must be decreased for patients with impaired renal purpose or hepatic disorder.pentobarbital will reduce the level or impact of buprenorphine subdermal implant by influencing hepatic/intestinal enzyme CYP3A4 metabo